Tenet Healthcare (NYSE:THC) Insider R. Scott Ramsey Sells 13,322 Shares

Tenet Healthcare Corporation (NYSE:THC) insider R. Scott Ramsey sold 13,322 shares of the company’s stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $205.11, for a total transaction of $2,732,475.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Tenet Healthcare Stock Up 0.4%

NYSE THC traded up $0.80 on Friday, reaching $204.99. The company had a trading volume of 508,188 shares, compared to its average volume of 1,428,240. The company has a debt-to-equity ratio of 2.27, a quick ratio of 1.63 and a current ratio of 1.71. The firm has a market capitalization of $18.02 billion, a price-to-earnings ratio of 14.05, a price-to-earnings-growth ratio of 0.89 and a beta of 1.53. The company’s fifty day moving average is $198.15 and its 200-day moving average is $175.72. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $217.43.

Tenet Healthcare (NYSE:THC) last released its earnings results on Tuesday, October 28th. The company reported $3.70 EPS for the quarter, beating the consensus estimate of $3.33 by $0.37. The firm had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. On average, research analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on THC shares. The Goldman Sachs Group began coverage on shares of Tenet Healthcare in a research note on Tuesday, October 14th. They set a “buy” rating and a $224.00 price objective for the company. JPMorgan Chase & Co. raised their price target on Tenet Healthcare from $190.00 to $200.00 and gave the company an “overweight” rating in a research note on Monday, August 4th. Cantor Fitzgerald upped their price objective on Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Wall Street Zen raised shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Saturday, July 26th. Finally, Raymond James Financial set a $245.00 price target on shares of Tenet Healthcare in a research note on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $226.25.

Hedge Funds Weigh In On Tenet Healthcare

Several institutional investors and hedge funds have recently modified their holdings of THC. SVB Wealth LLC bought a new stake in Tenet Healthcare in the 1st quarter valued at about $30,000. N.E.W. Advisory Services LLC bought a new stake in shares of Tenet Healthcare in the first quarter valued at approximately $31,000. Brooklyn Investment Group increased its stake in Tenet Healthcare by 908.7% during the 1st quarter. Brooklyn Investment Group now owns 232 shares of the company’s stock worth $31,000 after acquiring an additional 209 shares during the period. William B. Walkup & Associates Inc. bought a new stake in shares of Tenet Healthcare during the 3rd quarter valued at $32,000. Finally, Chung Wu Investment Group LLC bought a new position in shares of Tenet Healthcare in the second quarter worth $35,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.